Reprogramming of somatic cells with higher genome integrity, and use of non-integrating gene delivery methods and xeno-free cell culture conditions aid in the generation of iPSCs which are more suitable for disease modelling and clinical applications. We describe here an iPSC line generated using such conditions, which expressed all the pluripotency markers, retained normal karyotype and exhibited the potential for tri-lineage differentiation, both in-vitro and in-vivo. This is the first iPSC line available from a healthy Indian individual for researchers.
Pubmed ID: 29665501 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Nanog
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD235a (Glycophorin A)
View all literature mentionsThis monoclonal targets CD71 (Transferrin Receptor)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets residues surrounding Pro272 of human Sox17 protein
View all literature mentionsThis monoclonal targets aa 1464-1614 of human nestin
View all literature mentionsThis monoclonal targets Oct-4A (C30A3)
View all literature mentionsThis monoclonal targets Sox2
View all literature mentionsThis monoclonal targets SSEA4
View all literature mentionsThis monoclonal targets TRA-1-81 (TRA-1-81) Mouse mAb
View all literature mentionsThis monoclonal targets TRA-1-60(S)
View all literature mentions